 |
|
|
|
|
|
|
| Article 1 to 5 out of 5 concerning Merck & Co., Inc.
|
-
Melior Announces Research Collaboration with Merck
(09 Nov 2006)
Melior Discovery, Inc.announced that it has signed a research collaboration with Merck & Co., Inc.to evaluate the activity of select Merck neuroscience compounds utilizing elements of Melior's invivo Indication Discovery platform.Under the terms of ...
-
Stratagene and Merck Subsidiary, Rosetta Inpharmatics, enter into joint development and license agreement
(16 Aug 2006)
Development of RNA Purification System for Use in Molecular Diagnostics and Research Applications
Stratagene Corporation has entered into a joint development and license agreement with Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc., to create an automated solution for the isolation of nucleic acids from a variety of ...
-
Merck Sharp & Dohme Expands Singapore Facility with S$100 Million Investment
(31 Jul 2006)
MSD Technology Singapore Pte Ltd., a wholly owned subsidiary of Merck & Co. dedicated an expansion of its production facilities in Singapore. The expanded facilities are scheduled to open in the fourth quarter of 2006. Now in the final stages of ...
-
Robarts opens Canada's most advanced ultra-high field MRI facility
(03 Apr 2006)
Robarts Research Institute celebrated the opening of Canada's most advanced MRI facility in its Centre for Functional and Metabolic Mapping, which will design and apply new techniques to better understand and develop treatments for a range of ...
-
BioXell Enters License Agreement with Merck & Co., Inc. for TREM-1 Product Candidate and TREM Platform
(24 May 2005)
The Italian biopharmaceutical company BioXell SpA announced that it has signed an exclusive, worldwide license agreement with Merck & Co., Inc. for development of TREM related therapeutic and diagnostic products. Under the agreement, Merck obtains ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon